Bleomycin

DB00290ApprovedInvestigationalSmall moleculeCytoprotective Agent

Bleomycin is a chemotherapy agent used to treat various malignancies, including head and neck malignancy, lymphoma, and testicular tumors, among others. A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2 (B2 CAS # 9060-10-0).

Chemical structure of Bleomycin
Mechanism
Curator reviewed
Primary indication
For palliative treatment in the management malignant neoplasm (trachea, bronchus, lung), squamous cell carcinoma, and lymphomas.Curator reviewed · 7 structured indications
Formula / weight
C55H84N17O21S3 · 1415.552 g/mol (avg)
First approval
Canada, 2011 · United States, 2000
Also known as
Bleocin · Bleomicin
Code names
NSC-125066

Resolves to

Structure
InChIKeyOYVAGSVQBOHSSS-WXFSZRTFSA-OSMILES[H][C@](C)(NC(=O)[C@@]([H])(NC(=O)C1=NC(=NC(N)=C1C)[C@H](CC(N)=O)NC[C@H](N)C(N)=O)[C@@]([H])(OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(OC(N)=O)C1O)C1=CNC=N1)[C@@H](O)[C@H](C)C(=O)N[C@]([H])(C(=O)NCCC1=NC(=CS1)C1=NC(=CS1)C(=O)NCCC[S+](C)C)[C@@]([H])(C)O

What you can answer from here — as of August 31, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1,112Drug interactionsStructured to mechanism, not free text
Sign in
140Clinical trialsPhase, status and sponsor resolved per trial
Sign in
7Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
57Marketed productsAcross 10 countries and 37 labellers
Sign in
1ATC codeIncluding every combination product, plus 16 drug categories
Sign in
9+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Bleomycin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account